Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study

被引:0
|
作者
Wang, J. [1 ]
Jiang, P. [1 ]
Wei, L. [2 ]
Zou, L. [3 ]
Li, X. [4 ]
Wang, C. [5 ]
Sun, X. [6 ]
Ding, L. [7 ]
Yuan, X. [8 ]
Cheng, H. [9 ]
Wu, D. [10 ]
Cai, R. [11 ]
Yin, R. [12 ]
Zhang, J. [13 ]
Qiu, H. [14 ]
Wang, T. [15 ]
Gao, K. [16 ]
Zhuo, Y. [17 ]
Zhang, Y. [18 ]
Zhao, F. [19 ]
机构
[1] Peking Univ Third Hosp, Dept Radiat Oncol, Beijing, Peoples R China
[2] Air Force Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Xian, Peoples R China
[3] Dalian Med Univ, Affiliated Hosp 2, Dept Radiat Oncol, Dalian, Peoples R China
[4] Beijing Canc Hosp, Dept Radiat Oncol, Beijing, Peoples R China
[5] Liaoning Canc Hosp & Inst, Dept Gynecol, Shenyang, Peoples R China
[6] Inner Mongolia Med Univ, Affiliated Hosp, Dept Radiotherapy, Hohhot, Peoples R China
[7] Baotou Canc Hosp, Dept Radiotherapy, Baotou, Peoples R China
[8] Cangzhou Hosp Integrated TCM WM Hebei, Dept Oncol Chemoradiotherapy, Cangzhou, Peoples R China
[9] Henan Canc Hosp, Gynecol Oncol, Zhengzhou, Peoples R China
[10] Southern Med Univ, Nanfang Hosp, Dept Radiotherapy, Guangzhou, Peoples R China
[11] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiotherapy, Shanghai, Peoples R China
[12] Sichuan Univ, West China Univ Hosp 2, West China Womens & Childrens Hosp, Dept Oncol Chemoradiotherapy, Chengdu, Peoples R China
[13] Shanxi Canc Hosp, Gynecol Radiotherapy, Taiyuan, Peoples R China
[14] Wuhan Univ, Zhongnan Hosp, Dept Oncol Chemoradiotherapy, Wuhan, Peoples R China
[15] Second Hosp Jilin Univ, Dept Radiat Oncol, Changchun, Peoples R China
[16] Guangxi Med Univ, Tumor Hosp, Gynecol Oncol, Nanning, Peoples R China
[17] Zhangzhou Municipal Hosp Fujian Prov, Dept Radiat Oncol, Zhangzhou, Peoples R China
[18] Harbin Med Univ Canc Hosp, Dept Radiat Oncol, Harbin, Peoples R China
[19] Gansu Prov Canc Hosp, Dept Radiotherapy, Lanzhou, Peoples R China
关键词
D O I
10.1016/j.annonc.2023.09.1938
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
759P
引用
收藏
页码:S518 / S519
页数:2
相关论文
共 50 条
  • [1] An Open Label, Multicenter Clinical Study of Cetuximab Combined with Concurrent Chemo-radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of a Phase II Trial
    Yu, J.
    Wang, J. H.
    Sun, X. D.
    Wang, L. H.
    Zhu, G. Y.
    Feng, P. B.
    Ye, M.
    Lu, Y.
    Zhu, S. C.
    Liao, Z. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S309 - S309
  • [2] Nimotuzumab plus concurrent chemo-radiotherapy versus chemo-radiotherapy in unresectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis from a prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial (NXCEL1311 Study).
    Meng, Xue
    Zheng, Anping
    Wang, Jun
    Wang, Jianhua
    Li, Guang
    Zhu, Jun
    Ma, Hu
    Zhu, Xiaodong
    Shi, Anhui
    Dai, Chunhua
    Yan, Senxiang
    Wang, Buhai
    Qu, Zhongyu
    Han, Chun
    Sun, Xindong
    Ye, Ming
    Fan, Ruitai
    Huerxidan, Ni Yazi
    Wang, Xiaohong
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Concurrent chemo-radiotherapy in locally advanced NSCLC: Is it specially tailored for the squamous cell pathology?
    Chaudhuri, A.
    Cornelius, N.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S36 - S37
  • [4] Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
    Meng, Xue
    Zheng, Anping
    Wang, Jun
    Wu, Xiaoyuan
    Li, Guang
    Zhu, Jun
    Ma, Hu
    Zhu, Xiaodong
    Shi, Anhui
    Dai, Chunhua
    Yan, Senxiang
    Wang, Buhai
    Qu, Zhongyu
    Han, Chun
    Sun, Xindong
    Ye, Ming
    Fan, Ruitai
    Huerxidan, Niyazi
    Wang, Xiaohong
    Yu, Jinming
    BRITISH JOURNAL OF CANCER, 2023, 129 (11) : 1787 - 1792
  • [5] Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
    Xue Meng
    Anping Zheng
    Jun Wang
    Xiaoyuan Wu
    Guang Li
    Jun Zhu
    Hu Ma
    Xiaodong Zhu
    Anhui Shi
    Chunhua Dai
    Senxiang Yan
    Buhai Wang
    Zhongyu Qu
    Chun Han
    Xindong Sun
    Ming Ye
    Ruitai Fan
    Niyazi Huerxidan
    Xiaohong Wang
    Jinming Yu
    British Journal of Cancer, 2023, 129 : 1787 - 1792
  • [6] Efficacy and safety of nimotuzumab plus radiotherapy for elderly patients with locally advanced cervical squamous cell carcinoma
    Qu, A.
    Wang, J.
    Zhuo, Y.
    Liu, Z.
    Zhu, H.
    Wei, L.
    Sun, X.
    Gao, Y.
    Cheng, H.
    Zhao, F.
    Song, Y.
    Wen, Q. L.
    Zhou, X.
    Wang, P.
    Yang, J.
    Zou, L.
    Yuan, X.
    Wu, D.
    He, J.
    Zhang, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S519 - S519
  • [7] Efficacy and safety of cisplatin combined with paclitaxel concurrent radiotherapy in patients with locally advanced cervical squamous cell carcinoma
    Feng, Tao
    Zhang, Yuxin
    Zheng, Guanghao
    Lv, Xiaojuan
    Yan, Dingding
    Feng, Yue
    Lou, Hanmei
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2025, 36 (01)
  • [8] Nimotuzumab in combination with radiotherapy for elderly patients with locally advanced cervical squamous cell carcinoma: Results from a prospective, multi-center, open-label, single-arm trial
    Qu, Ang
    Wang, Jun Jie
    Zhuo, Yanhong
    Liu, Zi
    Zhu, Hong
    Wei, Lichun
    Sun, Xiaoge
    Gao, Yuhua
    Cheng, Huijun
    Zhao, Fengju
    Song, Yipeng
    Wen, QingLian
    Zhou, Xiaohong
    Wang, Ping
    Yang, Jialin
    Zou, Lijuan
    Yuan, Xiangkun
    Wu, Dongyue
    He, Jianli
    Zhang, Yun Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study
    Bouillet, T
    Diana, C
    Pailler, M
    Gozy, M
    Labrune, S
    Gervais, R
    Brechot, J
    Breau, J
    Chinet, T
    Morere, J
    LUNG CANCER, 2005, 49 : S166 - S167
  • [10] Cetuximab, paclitaxel, cisplatin and concurrent radiation in Chinese patients with locally advanced esophageal squamous cell carcinoma: An open-label, multicenter, phase II study.
    Yu, Jinming
    Meng, Xue
    Wang, Jian Hua
    Sun, Xindong
    Wang, Lv Hua
    Ye, Ming
    Feng, Ping Bo
    Zhu, Guang Ying
    Lu, You
    Han, Chun
    Zhu, Shu Chai
    Liao, Zhongxing X.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)